Orion Genomics, Novartis Collaborate On Epigenetic Biomarker Research | GenomeWeb

NEW YORK (GenomeWeb News) – Orion Genomics, a St. Louis-based epigenetic research tools and molecular diagnostics company, and Novartis Pharma's molecular diagnostics unit have entered into a multi-year collaboration and license agreement, Orion announced today.

The collaboration, aimed at discovering epigenetic markers related to a range of diseases, will involve mapping DNA methylation across the genome using Orion's MethylScope Technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.